Consolidated Balance Sheets - USD ($) $ in Millions	Nov. 30, 2023	Feb. 28, 2023
Current
Cash and cash equivalents (note 3)	$ 210	$ 295
Short-term Investments	0	131
Accounts Receivable, after Allowance for Credit Loss, Current	183	120
Other receivables (note 4)	8	12
Income taxes receivable	5	3
Other current assets (note 4)	44	182
Assets, Current, Total	450	743
Restricted cash and cash equivalents (note 3)	25	27
Long-term investments (note 3)	36	34
Other long-term assets (note 4)	66	8
Operating Lease, Right-of-Use Asset	41	44
Property, plant and equipment, net (note 4)	22	25
Intangible assets, net (note 4)	163	203
Goodwill (note 4)	597	595
Assets	1,400	1,679
Current
Accounts payable	17	24
Accrued liabilities (note 4)	125	143
Income taxes payable (note 5)	33	20
Debentures (note 6)	150	367
Deferred revenue, current (note 11)	183	175
Total current liabilities	508	729
Deferred revenue, non-current (note 11)	19	40
Operating lease liabilities	47	52
Other long-term liabilities	1	1
Total liabilities	575	822
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0	0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 585,339,555 voting common shares (February 28, 2023 - 582,157,203)	2,941	2,909
Deficit	(2,102)	(2,028)
Accumulated other comprehensive loss (note 9)	(14)	(24)
Total shareholders' equity	825	857
Total liabilities and shareholders' equity	$ 1,400	$ 1,679
Common issued (in shares)	585,339,555	582,157,203
Common outstanding (in shares)	585,339,555	582,157,203